key: cord-0955259-q5jhqnp7
authors: Picchiotti, N.; Benetti, E.; Fallerini, C.; Daga, S.; Baldassarri, M.; Fava, F.; Zguro, K.; Valentino, F.; Doddato, G.; Giliberti, A.; Tita, R.; Amitrano, S.; Bruttini, M.; Di Sarno, L.; Iuso, N.; Alaverdian, D.; Beligni, G.; Croci, S.; Meloni, I.; Pinto, A. M.; Gabbi, C.; Ceri, S.; Esposito, A.; Pinoli, P.; Crawley, F. P.; Frullanti, E.; Mari, F.; GEN-COVID Multicenter Study,; Gori, M.; Renieri, A.; Furini, S.
title: Post-Mendelian genetic model in COVID-19
date: 2021-01-29
journal: nan
DOI: 10.1101/2021.01.27.21250593
sha: b97bd3fb0c33c41e1383b823532471604f428dc7
doc_id: 955259
cord_uid: q5jhqnp7

Host genetics is an emerging theme in COVID-19 and few common polymorphisms and some rare variants have been identified, either by GWAS or candidate gene approach, respectively. However, an organic model is still missing. Here, we propose a new model that takes into account common and rare germline variants applied in a cohort of 1,300 Italian SARS-CoV-2 positive individuals. Ordered logistic regression of clinical WHO grading on sex and age was used to obtain a binary phenotypic classification. Genetic variability from WES was synthesized in several boolean representations differentiated according to allele frequencies and genotype effect. LASSO logistic regression was used for extracting relevant genes. We defined about 100 common driver polymorphisms corresponding to classical -threshold model-. Extracted genes were demonstrated to be gender specific. Stochastic rare more penetrant events on about additional 100 extracted genes, when occurred in a medium or severe background (common within the family), simulate Mendelian inheritance in 14% of subjects (having only 1 mutation) or oligogenic inheritance (in 10% having 2 mutations, in 11% having 3 mutations, etc). The combined effect of common and rare results can be described as an integrated polygenic score computed as: (nseverity-nmildness) +F (mseverity-mmildness) where n is the number of common driver genes, m is the number of driver rare variants and F is a factor for appropriately weighing the more powerful rare variants. We called the model -post-Mendelian-. The model well describes the cohort, and patients are clustered in severe or mild by the integrated polygenic scores, the F factor being calibrated around 2, with a prediction capacity of 65% in males and 70% in females. In conclusion, this is the first comprehensive model interpreting host genetics in a holistic post-Mendelian manner. Further validations are needed in order to consolidate and refine the model which however holds true in thousands of SARS-CoV-2 Italian subjects.

Coronavirus disease 2019 (COVID- 19) represents an important testing case for developing new models of complex disorders due to the combination of environmental and genetic factors. Unlike other multifactorial disorders, the main environmental factor can easily be identified through PCR-based tests on swab. Assuming a relatively low impact of viral genome variability [1] , the remaining variability might likely be associated with age and host genetics, including gender.

Genome-Wide Association Studies (GWASs) have identified a certain number of common polymorphisms in relevant genes. However, these associations do not fully explain the variability of clinical outcomes [2] [3] . The candidate gene approach has shown that, as with many other complex disorders, a simple Mendelian inheritance is also found in COVID-19, affecting some rare individuals with a defect in genes related to innate immunity [4] [5] .

In a previous study, we explored host genetics through Whole Exome Sequencing analysis (WES) in a cohort of 35 hospitalized COVID-19 patients, which led to the definition of a preliminarily combined model of rare and common variants impacting the clinical outcome [6] . Then, within the Italian GEN-COVID Multicenter Study, biospecimens from more than 1,000 SARS-CoV-2 positive individuals have been collected in the GEN-COVID Biobank (GCB), with clinical data stored in the related Patient Registry (GCPR), and genetic data have in the connected Genetic Data Repository (GCGDR) [7] . SNP genotyping of this cohort contributed to the identification of some loci associated with COVID-19 [3] , while WES analysis pinpointed additional common non biallelic polymorphisms [8] and rare variants [9] . However, an organic model explaining how common variants may combine with rare variants is still missing. In this study, we propose a new model for predicting the severity of COVID-19 using both common and rare variants. The model was defined in two steps. Initially, logistic regression was used to All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint identify a set of genes that are predictive for the severe or the mild phenotype of COVID- 19 . Association rules extracted using variants of these genes as input features revealed a robust link between the class of the variants (i.e., protecting or predisposing to the severe phenotype) and the actual phenotype, which supports the predictive capability of the selected genes. In the second step of the model, these predictive genes were used to define a score that separates the extreme COVID-19 phenotypes. This score was able to predict the phenotype in a testing dataset with accuracy of X, proving the predictive capacity of the strategy proposed.

Demographic and clinical characteristics of the data set were reported in [7] . The number of cases used in this study is 1,318. In order to obtain a clinical classification as independent as possible from age and gender, an Ordered Logistic Regression (OLR) model was used. Separately for the male and female cohorts, two OLR models were fitted using the age to predict the ordinal grading (0, 1, 2, 3, 4) dependent variable (Figure 1 ).

Then, each patient had clinical classification equal to: 0 (mild), if the actual patient grading was below the one predicted by the OLR; or 1 (severe), if the grading was above the OLR prediction. The patients with a predicted gradient equal to the actual gradient were excluded from the LASSO analysis, by which we wanted to compare the "extreme ends" .

Whole Exome Sequencing with at least 97% coverage at 20x was performed using the Illumina NovaSeq6000 System (Illumina, San Diego, CA, USA). Library preparation was performed using the Illumina Exome Panel (Illumina) according to the manufacturer's protocol. Library enrichment was tested by qPCR, and the size distribution and concentration were determined using Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). The Novaseq6000 System (Illumina) was used for DNA sequencing through 150 bp paired-end reads. Variants calling was performed according to the GATK4 best practice guidelines, using BWA for mapping and ANNOVAR for annotating. WES data were represented in a binary mode on a gene-by-gene basis.

In the boolean representation of bi-allelic polymorphisms, all the unique combinations (mutually exclusive) of common variants (frequency > 1%) with frequency in the cohort above 5% were selected. These unique combinations were used to define a matrix of M by N input features (M and N being respectively the number of combinations and samples), with element j,i equal to 1 if the combination of common variants j is present in sample i.

Three models were proposed for the binary representation of rare variants: autosomal dominant (AD), autosomal recessive (AR), and X-linked (XL). Only coding variants (missense, non-sense, and ins/del), as well as splicing mutations, were considered together with any pathogenic mutations (coding and non-coding) with a frequency below 5% (Phe508del in CFTR being 1.1% in the non-Finnish European population). In the AD model, the input feature j,i is 1 if gene j in sample i has at least one variant with a frequency ≤ 1%. In the AR model, the input feature j,i is 1 if gene j in sample i has either a variant with a frequency ≤ 1% in a homozygous state or two variants. In the XL model, only to the male cohort and only genes on chromosomes X are considered. The input feature j,i is 1 if gene j in sample i has a variant with frequency ≤ 1% (hemizygous state).

Among 1,318 samples, after PCA analysis, 63 outliers were removed. Those corresponded to no-white subjects (32 hispanic, 12 black, 18 asian, 1 arabic). In the boolean representation concerning rare variants, genes with higher percentages of mutations than expected as defined by knee analysis were considered artifacts and excluded from the analyses (Fig. S1) . Among the 18,085 annotated genes 12 genes were excluded from the analysis due to error in the annotation such as ARSD and VCX family gene.

The binary classification problem, i.e., mild/severe cases, was solved by a logistic regression model, one of the most common and successful Machine Learning (ML) 1) common bi-allelic coding haplotypes of autosomal genes (hetero plus homo versus wt) extracting common variants acting in a heterozygous state; 2) common bi-allelic coding haplotypes of autosomal genes (homo versus hetero and wt) extracting common variants acting in a homozygous state; 3) common bi-allelic coding haplotypes of X-linked genes (hemy versus wt) extracting common variants acting in a hemizygous state in males; 4) rare variants of autosomal genes (hetero plus homo versus wt) extracting rare variants acting in heterozygous state; 5) rare variants of autosomal genes (homo versus hetero and wt) extracting rare variants acting in a homozygous state; 6) rare variants of X-linked genes (hemy versus wt) extracting rare variants acting in a hemizygous state in males.algorithms for binary classification tasks with probabilistic interpretation. In order to enforce both the sparsity and the interpretability of the results, the model was trained with the additional LASSO (Least Absolute Shrinkage and Selection Operator) regularization term. By denoting with the coefficients of the logistic regression model and by lambda (λ) the strength of the regularization, the LASSO regularization term of the loss,

| |, has the effect of shrinking the estimated coefficients to 0, providing a All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint feature selection method for sparse solutions within the classification task. The weights of the logistic regression algorithm can be interpreted as the feature importances of the subset of the most relevant features for the task [10].

The fundamental hyper-parameter of the logistic regression algorithm is the strength of the LASSO term, which was tuned with a grid search method on the average area under the Receiver Operating Characteristic (ROC) curve for the 10-fold crossvalidation. 50 equally spaced values in logarithmic scale in the range [10 −3 , 10 2 ] were tested. The optimal regularization parameter was selected as the one with the best trade-off between the simplicity of the model and the cross-validation score, i.e., as the highest value providing an average score closer than one standard deviation from the highest score. The rationale of this method is to select the most important genes (and not necessarily the entire set of genes contributing to COVID-19 variability). Data preprocessing was coded in Python, whereas for the logistic regression model, the scikit-learn module with the liblinear coordinate descent optimization algorithm was used.

Association rules are statements in the form "X implies Y", where, in the current study, X indicates a set of mutated genes and Y indicates the clinical classification of a patient.

Association rules can be mined from the data using apriori algorithm. Each association rule is associated with a support, that corresponds to the number of patients for which the antecedent X holds (i.e., patients that have all the genes in the X set mutated) and a confidence, that is the percentage of the patients in the support for which the consequent Y holds. The statistical significance of an association rule can be assessed by comparing the distributions of the values of Y in the set of patients harboring the mutations on the X genes and of the set of all the others, by means of the Fisher's exact test. In this study, we randomly split the patients in train (80%) and test (20%) sets. We mined the rules on the All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint training set only and used a grid search approach to identify the best pair of support and confidence thresholds. Then, we selected only those rules having a p-value lower than 0.05 on the training set. The remaining rules are further tested on the test set and only those having a Bonferroni corrected p-value lower than 0.05 are kept. For mining association rules we used the arules library (in R).

We mined separately for females and males all significant association rules having support >= 0.08 and confidence >= 0.8, by considering the top genes as extracted by Lasso Logistic Regression. The assessment requires to consider which genes are assembled within rules which associate with either mild or sever course of COVID-19; a confirmation of the model requires genes associated with mild course to be mildness genes, and genes associated with severe course to be severity genes, whereas rules are assembled by our method regardless of a prior assignment to these categories. We also selected enough rules to be associated with high percentages of patients (ranging from 90% of females to 94% of severe cases of males and 99% of mild cases of males).

The proposed model extends the standard "threshold model" of common polymorphisms to a more general framework, including the effect of rare variants. The main hypothesis of the model is to describe the combined effect of common and rare results by means of the following "integrated polygenic score" (IPGS):

In equation 1, and are the number of common polymorphic driver genes conferring severity or mildness respectively to COVID-19; while and are the number of driver rare variants conferring severity or mildness respectively to COVID-19. The multiplicative factor was included to model a more penetrant effect of All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint rare variants with respect to common variants. In order to identify the optimal value of this weighting factor, for each value of F in the range 0-20, the silhouette coefficient of the clustering (mild vs severe) results was calculated. The optimal value of F was defined as the one that maximizes the silhouette coefficient, i.e., provides the best separation between the two clusters.

Whole Exome Sequencing (WES) data stored in the Genetic Data Repository of the GEN-COVID Multicenter Study (GCGDR) and coming from biospecimens of 1,300 SARS-CoV-2 PCR positive subjects were used for the analysis [7] . Since age and gender are strong determinants of the clinical outcome, we stratified the cohort by gender and then applied ordered logistic regression to re-classify the patients (Figure 1 ) as: i) severe, subjects falling above the expected treatment according to age; ii) intermediate, subjects matching the expected treatment according to age; iii) mild = subjects falling below the expected treatment according to age. This novel classification is expected to be independent of age, and consequently, it should facilitate the identification of the genetic factors responsible for COVID-19 severity.

We then used severe versus mild cases defined by ordered logistic regression as inputs for a series of logistic regression models for LASSO regularization. The purpose of these logistic models is to identify which features are better predictive for either severity or mildness. Six different types of genetic variability were represented in a boolean manner and tested separately: All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint For common bi-allelic haplotypes (hetero plus homo versus wt), we identified 19 genes ordered by importance using the cohort with both genders (Figure S2a) (Table S1) .

We then repeated the analysis with gender stratification. We found that the majority of genes, 16 out of 19, are gender-specific, i.e., found in one gender only The logistic models training with gender stratified cohorts pinpoints an increased number of predictive genes. Indeed, 107 genes were identified in males only and 44 in females only versus 19 in the cohort of both genders. The presence of gender specific effects is the most likely explanation for the increase in the number of predictive genes in gender stratified cohorts (Figure 2) . Therefore, we decided to proceed with stratification by gender as gender medicine appears to be much more relevant in COVID-19 than in other disorders. In the next two sections, the genes identified in the male and female cohorts are presented. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint

Using LASSO logistic regression on the boolean representation of common biallelic haplotypes and rare variants, we identified 293 relevant genes in males: 154 of them having common variants/haplotypes, while 139 having rare variants.

Among the 154 genes with common variants/haplotypes, in 109, the associated genotype was heterozygous (and homozygous), in 11 homozygous (120 being on autosomes), and in 34 hemizygous, the gene being on the X chromosome. Among the 139 genes with rare variants, in 11, the variant was present in at least one allele (AD-like inheritance), in 69, the variant was present in at least two alleles (AR-like inheritance), and in 59, the variant was hemizygous, the gene being on the X chromosome (XL-like inheritance). Table S8 , S11 and S13).

Among relevant extracted mildness genes with common variants are:

p.Asp611Asn (hetero) of N4BP2, required for influenza virus infection and Ile57Val

(hetero) of AURKA, a cell cycle regulator downregulated during SARS-CoV-2 infection, All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Table S8 , S11 and S13). 

Using LASSO logistic regression on the boolean representation of common biallelic haplotypes and rare variants, we identified 122 relevant genes in females, 78 of them having common variants/haplotypes, while 44 having rare variants. Among the 78 genes with common variants/haplotypes, in 44, the associated genotype was at least heterozygous, in 34 homozygous. Among the 44 genes with rare variants, in 36, the variant was present in at least one allele (AD-like inheritance), in 8, the variant was present in at least two alleles (AR-like inheritance). All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Table S9 , and S12).

Data mining for association rules reveals that 90% of cases are covered by the rules indicated in Figure S3c and Figure S3d . Among severity rules are TP53 Pro33Arg and EPCAM Met 115Thr, an adhesion molecule involved in HBV replication (Figure S3c) .

Among the mildness rules in females are APOBEC1 Met80Ile conferring more activity to the RNA editing defence against RNA virus and CFHR4 Glu125Asp controlling complement ( Figure S3d ). All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint

In the previous sections, the protocol used to identify predictive genes for the severe/mild phenotypes were presented. The plausibility of these genes is supported by biological evidence, and by the fact that association rules for the severe phenotype mostly used genes identified by logistic regression as predisposing to severity, and vice versa.

This agreement among biological knowledge and two independent modelling approaches pushed us to further explore the possibility to combine variants information on these genes into a predictive model of the phenotype. The proposed model extends the standard "threshold model" of common polymorphisms to a more general framework, including both the effect of common and rare variants. In order to discuss the functioning of the model, it will be assumed that the severity of COVID-19 is primarily determined by 200 genes, with approximately half of them presenting common variants, and the remaining rare variants. In case that each variant carries the same relative risk, subjects with approximately the same number of common variants in mildness and severity genes will behave according to their age (black dots in the ordered logistic regression of Figure 1 ).

Instead, subjects with unbalanced variants, that is with a higher number of mildness or severity variants, will more likely belong to the corresponding phenotype, with a probability that increases as the difference between the number of mildness and severity variants increases. Looking for the epidemiological data of the total percentage of those who are severely ill (intubated or CPAP-BiPAP), one should infer the exact number of genes involved in the model and the exact percentage necessary for the threshold effect.

In addition to the cumulative effect of common variants, another group of genes (for simplicity again assumed as composed by 100 genes) may be affected by a rare mutation according to an autosomal dominant, autosomal recessive, or X linked model (with similar probabilities in males). Rare variants have a MAF less than 1%, and like the All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint common variants half of them (about 50) are conferring severity, and half of them (about 50) are conferring mildness when the alternate sequence is present.

Let us suppose a rare mutation occurring in a neutral or severity background of commons. In that case, it will be either a more severe or earlier disease segregating as a Mendelian inheritance (because family members are likely to have identical or similar combinations of common variants). If a rare occurs in a mildness background, the penetrance will depend on the strength of the rare (and likely it is not penetrant).

If a mildness rare occurs in a neutral or mildness background, the individual will be even more mild (for example, an individual with the persistence of antibodies far away from the vaccine or infection). If rare mildness variants occur in a harmful background, its effect will depend on the strength (relevance) of mildness (the type of gene and of mutation) and location of the gene in the pathophysiological process. For example, individuals with rare variants in FACL4 (which prevents the accumulation of lipid microparticles necessary for the development of the virus) could have milder symptoms even in a negative background (because the action is upstream). On the other hand, for example, there are individuals who are fine after infection but whose swab remains positive for a long time. These could be individuals with common mildness variants but "severity rare mutations" favoring the spread of the virus on the tissues. However the downstream process then appears milder because they respond well by innate and adaptive immunity.

The number of rare variants that each individual can have varies from 0 to more than 6. In individuals without rare variants, the prediction of severity is based on the common variants only. In individuals with rare variants, the correct prediction is made considering common and rares together. In the case of more than one rare in the same sense (e.g., more than one severity rare), the segregation simulates the oligogenic model (digenic, trigenic, etc.). All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint

In the cohort of 1,300 SARS-CoV-2, we tested the above-reported model in which rare variants contribute together with common polymorphisms to COVID-19 liability. For each patient of the cohort, by counting the mutations of the genes extracted by LASSO logistic regression we obtained the integrated polygenic scores reported in the frequency distribution ( Figure 5 ) separately for severe (red) and mild (green) phenotypes.

The calibrated F factor, i.e. the coefficient for which the mean silhouette coefficient is maximum, is shown in Figure 5 for the male (1,6) and female (2,1) cohorts.

In the overall cohort, Mendelian inheritance is simulated when rare variants occurred in a medium or severe background (14% of subjects having only 1 susceptibility mutation) and oligogenic inheritance (10% having 2 susceptibility mutations, 11% having 3 mutations, etc.).

In the cohort 15 familial cases were collected and analysed. Segregation analysis using integrated polygenic score perfectly matched the phenotype in all families except one (Figure 6 ). Looking at very rare variants the severely affected member of this family had a very rare pathogenic mutation in IFNAR1. The frequency of IFNAR1 variants is too low to identify them in a cohort of this size by logistic regression.

We repeated the whole analysis by splitting the cohort in a training set (90%) and a testing set (10%) in order to test whether the proposed model is able to generalize the predictions to unseen samples. The total number of genes identified in the training set was 240 in males and 198 in females. Considering only those that were extracted in more than All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint 50% of the 5 repeated cross-validations, we set the number of very relevant genes for both males and females at 135. We therefore tested the predictivity of the model by applying the polygenic score with this set of genes to the testing set. The calibration of F was at 2 for males and at 1 for females. The frequency distributions of the integrated polygenic score are reported in Figure 7 for the male and the female cohorts. In the upper plots (Panels a and b) the distributions for the training set (90%) are reported whereas the testing set results (10%) are in the lower plots (Panels c and d). The red distribution is related to the severe phenotypes and the green one to the mild phenotypes. Predictivity of the method (ROC-AUC) is 65% and 70%, for males and females respectively.

Using machine learning methodologies, we identified a subset of genes predisposing to severe COVID-19 and a subset of genes preventing the development of such a disease, thus conferring a mildness effect (Figure 2) . Most importantly, we defined a new genetic model for explaining genetic susceptibility to COVID-19 (Figure 3) . The proposed method has a number of innovative approaches.

First, the clinical modified WHO outcome scale was combined with the age, that is the main "non genetic" factor influencing clinical outcome, dividing subjects in three categories only: those having a clinical outcome as expected just for age and those having either a worse or better clinical outcome. The last two were selected as extreme ends of phenotype and used for selecting relevant genes.

Second, the method is gene based and processes the genes in a Boolean manner, i. e. having or not having that variant. For both common and rare variants the Boolean classification was repeated three times corresponding of having at least the heterozygous genotype (dominant modes), homozygous genotype (recessive model) or hemizygous genotype (X-linked model) for genes on chromosome X and males only. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint Third, we reasoned that not rarely (3413) genes have more than one coding polymorphism. All the coding changes may move the function of the protein either in the same direction (for example lowering or increasing the function) or in the opposite direction therefore cancelling each other. We used a "coding haplotype" approach for classifying polymorphic variability in a Boolean manner: we counted the most common combinations (not all theoretical combinations are present due to linkage disequilibrium) and assigned the score of 1 to each gene if the specific combination is present or zero if not. Again the Boolean classification was repeated three times corresponding to having at least the heterozygous genotype, homozygous genotype or hemizygous genotype for genes on chromosome X and males only.

Fourth, the method is treating separately males and females thus representing the first approach fully translating into practice gender medicine. Indeed, male patients affected by COVID-19 undergo a more severe clinical course.

Fifth, the method we used for gene selection, based on Lasso regularization for a logistic regression classifier, is indirectly confirmed by association rules, produced by a different method, as protection genes spontaneously associate with mild cases and severity genes associate with severe cases. Finally, the method is able to take into account both common and rare variability.

To our knowledge this is the first method able to synthesise in an holistic approach both variabilities, which usually are treated separately: using polygenic score from GWAS approach for the common variability and Mendelian model for rare variability. We therefore suggest to call this method "post-Mendelian model".

However, the method is still far from perfect and needs further improvement. For example the method is treating each gene as having the same weight within common or within rare variants. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint Furthermore, a number of genetic variabilities are missed in the model such as: i) non biallelic common polymorphisms like polyamino acid repeats, known to contribute to COVID-19 [8] ; ii) variability due to germline CNV; iii) variability due to somatic mutations, both CNV and SNP [12] [13] ; iv) very rare variants or private variants, whose frequency is not enough to be detected by LASSO logistic regression.

Further studies are needed in order to improve the model taking into account the above reported variability and increase prediction performances.

We were able to identify a set of genes in which common polymorphisms confer either severity or mildness against COVID-19 severity. We also identified another set in which rare variants confer either severity or mildness to COVID-19 disease. We have finally defined a new post-Mendelian genetic model, based on an analysis of common and rare variants, that can explain severity in COVID-19.

The model is good enough to extract the relevant genes of a specific patient and understand the main pathogenic pathways useful for assessing a personalized co-adjuvant treatment flanking the current use of cortisone. It is still young to be used as a predictive tool in not yet infected individuals, but it represents the basis for a second release of the model with potential predictive use.

By better understanding the role of host genetics in COVID-19 susceptibility, we are also in a stronger position to identify public health measures that will help to curb the impact of the disease on society as a whole. This should help us to genetically screen already affected patients as well as individuals who may potentially be patients in order to predict those who are more or less susceptible to developing COVID-19 post-infection. It should further help us in, not only reassigning therapeutics or developing new interventions (including vaccines), but also in decision-making regarding therapeutics and perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint On the Y axis, the grading according to patients' treatment is reported (4=intubated; 3=CPAP/biPAP; 2=oxygen therapy; 1=hospitalized without oxygen support; 0=not hospitalized oligo-asymptomatic patients). On the X axis, age is reported. Red dots represent subjects falling above the expected treatment according to age (hence considered severe), green dots are subjects falling below the expected treatment according to age (hence considered mild) and black dots are subjects matching the expected treatment according to age (hence considered intermediate).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint in immune response and low density lipoprotein receptor family member LRP8 having a role in the suppression of innate response. Treatment with immunosuppressive agents may be an option in this patient.

Frequency distributions of the IPGS score for the male cohort (Panels a and c) and female cohort (Panel b and d) . In the upper plots the distributions of integrated polygenic score and phenotype distribution for the training set (90%) are reported; in the lower plot the distribution for the testing set (10%) is reported. The red distribution is related to the severe phenotypes and the green one to the mild phenotypes. The predictivity is 65% for males and 70% for females.

In the boolean representation of rare variants, the genes with a number of mutations higher than a threshold are excluded from the LASSO analysis. The threshold has been defined by the knee-analysis of the empirical cumulative density function of the number of mutations for the genes in the overall cohort.

Regression. Comparison of extreme ends of phenotype: subjects of class 1 (red in Fig.1) versus class 0 (green in Fig. 1 ) as defined by ordered logistic regression. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint variants plus wt genotype and using both males and females (S2d) or only males (S2e).

For females (S2f) the performances are below the random guess. the error bar is given by the standard deviation of the average ROC-AUC within the 10 folds; the red point corresponds to the parameter chosen for the fitting procedure.

We ordered the rules, each typically assembling four to five genes, by decreasing support.

We then built curves of cumulative counters of distinct patients associated with at least one such rule; we considered as preferred cutting point of each curve a point at the start of a "plateau" such that cumulative counter is relative to more than 90% of patients (actually, 90% of females, 94% of severe cases of males and 99% of mild cases of males). The most remarkable aspect of this construction, obtained by a data mining method which is All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint completely different from the ML-based method used for gene selection, is that genes assembled within mined rules are "coherent": both for males and females, mildness genes associate with mild cases and severity genes associate with severe cases. Out of several hundred genes included in the rules, only four are "incoherent" (marked in yellow). They are also widely mutated and hence not really significant, as genes PRSS5, APOBEC1 and SLC24A3 are mutated respectively in 55%, 75% and 86% of females, and gene FOXR2 is confidence is illustrated by a graded scale. Top rules are selected based on the cumulative number of distinct patients associated with at least one rule (90%). Remarkably, all genes All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint of top rules are mildness genes except gene PRSS55, which is present in 55% of female patients. Table S1 . Common bi-allelic coding haplotypes of autosomal genes (hetero plus homo versus wt) using the cohort with both genders. Table S2 . Common bi-allelic coding haplotypes of autosomal genes (hetero plus homo versus wt) in male cohort. Table S3 . Common bi-allelic coding haplotypes of autosomal genes (hetero plus homo versus wt) in female cohort. Table S4 . Common bi-allelic coding haplotypes of autosomal genes (homo versus hetero and wt) using the cohort with both genders. Table S13 . Rare variants of X-linked genes (hemy versus wt) in males.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.27.21250593 doi: medRxiv preprint

Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci Rep

Severe Covid-19 GWAS Group

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

Pasko, critical illness in Covid-19

Epub ahead of print

Viral and host factors related to the clinical outcome of COVID-19

Clinical and molecular characterization of COVID-19 hospitalized patients

Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research

Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in males

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males

COVID-19 pandemic: a mobility-dependent SEIR model with undetected cases in Italy

Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer. medRxiv

Massimo Vaghi 24 , Antonella D'Arminio Monforte 25 , Esther Merlini 25 , Federica Gaia Miraglia 25

67) Department of Medical, Surgical and Neurological Sciences

71) Unit of Infectious Diseases

Fondazione per la ricerca Ospedale di Bergamo

Istituti Clinici Scientifici Maugeri, IRCCS, Department of Cardiac Rehabilitation

Cardiac Rehabilitation Unit, Fondazione Salvatore Maugeri, IRCCS, Scientific Institute of Milan

The data and samples referenced here are housed in the GEN-COVID Patient Registry and the GEN-COVID Biobank and are available for consultation. You may contact the corresponding author, Prof. Alessandra Renieri (e-mail: alessandra.renieri@unisi.it).